Krystal Biotech, Inc. (KRYS) Revenue 2021–2025
Krystal Biotech, Inc. (KRYS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$389.1MFY2025 · since FY2021: $0 → $389.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $389.1M | +33.9% |
| FY2024 | $290.5M | +473.0% |
| FY2023 | $50.7M | — |
| FY2022 | $0 | — |
| FY2021 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRYS financial trends
KRYS Net incomeKRYS Net marginKRYS Gross profitKRYS Gross marginKRYS Operating incomeKRYS Operating marginKRYS Operating cash flowKRYS Free cash flowKRYS Capital expendituresKRYS Return on equityKRYS Stock buybacksKRYS Dividends paidKRYS Total assetsKRYS Total liabilitiesKRYS Shareholders’ equityKRYS overview →